A Moderate Walking Test Predicts Survival in Women With Cardiovascular Disease.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
09 2023
Historique:
received: 25 10 2022
revised: 21 02 2023
accepted: 21 02 2023
medline: 21 8 2023
pubmed: 6 3 2023
entrez: 5 3 2023
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is the principal cause of death in U.S. women. Peak oxygen uptake is strongly related to mortality and CVD. This study aimed to investigate the association between estimated peak oxygen uptake, determined using a moderate 1-km walking test, and all-cause mortality in female patients with stable CVD. Of the 482 women in our registry between 1997 and 2020, we included 430 participants in the analysis (aged 67 [34-88] years). A Cox proportional hazard model was used to determine the variables significantly associated with mortality. On the basis of the peak oxygen uptake estimated using the 1-km walking test, the sample was subdivided into tertiles, and mortality risk was calculated. The discriminatory accuracy of peak oxygen uptake in estimating survival was assessed by receiver operating characteristic curves. All results were adjusted for demographic and clinical covariates. A total of 135 deaths from any cause occurred over a median of 10.4 years (IQR=4.4-16.4), with an average annual mortality of 4.2%. Estimated peak oxygen uptake was a stronger predictor of all-cause mortality than demographic and clinical variables (c-statistic-0.767; 95% CI=0.72, 0.81; p<0.0001). The survival rate decreased from the highest tertile of fitness to the lowest. Compared with the lowest group, hazard ratios (95% CIs) for the second and third tertiles were 0.55 (0.37, 0.83) and 0.29 (0.16, 0.51), respectively (p for trend <0.0001). Higher peak oxygen uptake levels were associated with a lower risk of all-cause mortality. The indirect estimation of peak oxygen uptake using the 1-km walking test is feasible and can be applied for risk stratification among female patients undergoing secondary prevention programs.

Identifiants

pubmed: 36871638
pii: S0749-3797(23)00115-0
doi: 10.1016/j.amepre.2023.02.025
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-504

Informations de copyright

Copyright © 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Andrea Raisi (A)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Tommaso Piva (T)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Jonathan Myers (J)

Division of Cardiology, Palo Alto VA Medical Center, Palo Alto, California; Stanford University School of Medicine, Stanford, California; Healthy Living for Pandemic Event Protection Network, Chicago, Ilinois.

Rosario Lordi (R)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; Public Health Department, Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy.

Valentina Zerbini (V)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy. Electronic address: valentina.zerbini@unife.it.

Sabrina Masotti (S)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Giorgio Chiaranda (G)

Public Health Department, Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy; General Directorship for Public Health and Integration Policy, Emilia-Romagna Region, Bologna, Italy.

Giovanni Grazzi (G)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; Healthy Living for Pandemic Event Protection Network, Chicago, Ilinois; Public Health Department, Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy.

Gianni Mazzoni (G)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; Public Health Department, Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy.

Simona Mandini (S)

Center for Exercise Science and Sports, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH